← All trials
NCT04521751
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 7, 2020
- Primary completion
- Apr 6, 2021
- Completion date
- Apr 13, 2021
- First posted
- Aug 21, 2020
- Last posted
- Aug 21, 2020
- Enrollment
- 156
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Empros Pharma ABLead sponsor
- Clinical Trial Consultants ABCollaborator
- Clinical Trial Consultants ABOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.